Live from CROI 2023 - Mosaico and the Future of HIV Vaccines

We have two CROI Episodes today - and this episode, brought to you with APHA, AVAC and CASPR, Yvette and Ben chat with Dr. Nyaradzo Mgodi University of Zimbabwe and Ntando Yola, APHA, to take stock of the results of the Mosaico trial (which was recently discontinued because, while safe, it was ineffective), the role of bNAbs (broadly neutralizing antibodies) in treating or potentially cure rapidly evolving viruses like HIV - all from a uniquely African perspective.

croiconference.org" target="_blank" rel="noopener noreferrer">https://www.croiconference.org
ashotinthearmpodcast.com" target="_blank" rel="noopener noreferrer">https://www.ashotinthearmpodcast.com
avac.org" target="_blank" rel="noopener noreferrer">https://www.avac.org
org.za/" target="_blank" rel="noopener noreferrer">https://apha.org.za/
avac.org/coalition-accelerate-support-prevention-research-caspr" target="_blank" rel="noopener noreferrer">https://www.avac.org/coalition-accelerate-support-prevention-research-caspr
niaid.nih.gov" target="_blank" rel="noopener noreferrer">https://www.niaid.nih.gov
cdc.gov" target="_blank" rel="noopener noreferrer">https://www.cdc.gov
iasusa.org" target="_blank" rel="noopener noreferrer">https://www.iasusa.org
unaids.org" target="_blank" rel="noopener noreferrer">https://www.unaids.org
state.gov/pepfar" target="_blank" rel="noopener noreferrer">https://www.state.gov/pepfar

#CROI_2023 #HIV #prevention #treatment #vaccine #pandemics #cure #COVID #ethics #placebo